Legal Representation
Attorney
Theresa Conduah
USPTO Deadlines
Next Deadline
426 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-08)
Due Date
September 08, 2026
Grace Period Ends
March 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 27, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 27, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Mar 27, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Dec 18, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Dec 18, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Dec 18, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Dec 18, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Sep 8, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 6, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Aug 5, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Aug 4, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Aug 4, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Jul 22, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Jul 22, 2020 | IUAF | S | USE AMENDMENT FILED |
Jan 25, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jan 23, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 23, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
Jan 23, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jul 23, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
May 28, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
May 28, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
May 8, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Apr 22, 2019 | ALIE | A | ASSIGNED TO LIE |
Apr 4, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Apr 4, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Apr 4, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Apr 4, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Apr 4, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Apr 3, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 21, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Feb 13, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jan 25, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 044
Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance
First Use Anywhere:
Jan 31, 2019
First Use in Commerce:
Jan 22, 2020
Additional Information
Design Mark
The mark consists of a gray square on the lower left side and a red square on the upper right side, and the gray wording "HeartCare" to the right of the design.
Color Claim
The color(s) gray and red is/are claimed as a feature of the mark.
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEART CARE"